- Home
- GAUZ vs PRQR Comparison
GAUZ vs PRQR Comparison
Compare GAUZ & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAUZ
- PRQR
- Stock Information
- Founded
- GAUZ 2009
- PRQR 2012
- Country
- GAUZ Israel
- PRQR Netherlands
- Employees
- GAUZ N/A
- PRQR N/A
- Industry
- GAUZ Industrial Machinery/Components
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- GAUZ Miscellaneous
- PRQR Health Care
- Exchange
- GAUZ Nasdaq
- PRQR Nasdaq
- Market Cap
- GAUZ 179.5M
- PRQR 153.5M
- IPO Year
- GAUZ 2024
- PRQR 2014
- Fundamental
- Price
- GAUZ $9.53
- PRQR $1.87
- Analyst Decision
- GAUZ Strong Buy
- PRQR Strong Buy
- Analyst Count
- GAUZ 4
- PRQR 4
- Target Price
- GAUZ $21.75
- PRQR $3.38
- AVG Volume (30 Days)
- GAUZ 42.2K
- PRQR 134.0K
- Earning Date
- GAUZ 11-10-2024
- PRQR 11-05-2024
- Dividend Yield
- GAUZ N/A
- PRQR N/A
- EPS Growth
- GAUZ N/A
- PRQR N/A
- EPS
- GAUZ N/A
- PRQR N/A
- Revenue
- GAUZ $89,751,000.00
- PRQR $16,902,389.00
- Revenue This Year
- GAUZ $46.49
- PRQR $189.85
- Revenue Next Year
- GAUZ $35.80
- PRQR $25.22
- P/E Ratio
- GAUZ N/A
- PRQR N/A
- Revenue Growth
- GAUZ 36.53
- PRQR 290.57
- 52 Week Low
- GAUZ $8.17
- PRQR $1.11
- 52 Week High
- GAUZ $17.10
- PRQR $3.29
- Technical
- Relative Strength Index (RSI)
- GAUZ N/A
- PRQR 42.46
- Support Level
- GAUZ N/A
- PRQR $1.87
- Resistance Level
- GAUZ N/A
- PRQR $2.00
- Average True Range (ATR)
- GAUZ 0.00
- PRQR 0.09
- MACD
- GAUZ 0.00
- PRQR -0.03
- Stochastic Oscillator
- GAUZ 0.00
- PRQR 12.84
About GAUZ Gauzy Ltd. Ordinary Shares
Gauzy Ltd is a integrated light and vision control company, Its products include suspended particle device, or SPD, and liquid crystal, or LC, films for smart glass applications, as well as camera monitoring systems, or CMS, and other advanced driver assistance systems, or ADAS, solutions. It has three operating segments. Architecture and automotive segment focuses on sales that enable OEMs to incorporate the Company's technology in glass rooftops, side windows and windshields. Safety tech segment focuses on sales of advanced driver assistance systems for buses, coaches, recreational vehicles and specific vehicles. Aeronautics segment focuses on the sale of shading and cabin management systems in private and commercial aircraft and helicopters. Key revenue is generated from Aeronauctis.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.